Acuitas Investments LLC Reduces Position in KORU Medical Systems, Inc. $KRMD

Acuitas Investments LLC lessened its stake in KORU Medical Systems, Inc. (NASDAQ:KRMD) by 53.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 185,353 shares of the company’s stock after selling 217,141 shares during the period. Acuitas Investments LLC owned about 0.40% of KORU Medical Systems worth $710,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the company. Geode Capital Management LLC boosted its holdings in shares of KORU Medical Systems by 101.3% during the second quarter. Geode Capital Management LLC now owns 997,147 shares of the company’s stock valued at $3,571,000 after acquiring an additional 501,875 shares during the period. First Light Asset Management LLC raised its position in KORU Medical Systems by 5.1% in the second quarter. First Light Asset Management LLC now owns 4,681,626 shares of the company’s stock worth $16,760,000 after acquiring an additional 226,700 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in KORU Medical Systems by 189.5% during the first quarter. Goldman Sachs Group Inc. now owns 242,781 shares of the company’s stock valued at $617,000 after purchasing an additional 158,914 shares during the last quarter. Archon Capital Management LLC raised its position in shares of KORU Medical Systems by 23.5% during the second quarter. Archon Capital Management LLC now owns 700,147 shares of the company’s stock worth $2,507,000 after purchasing an additional 133,277 shares during the period. Finally, Jane Street Group LLC boosted its holdings in shares of KORU Medical Systems by 136.7% in the first quarter. Jane Street Group LLC now owns 163,137 shares of the company’s stock worth $414,000 after buying an additional 94,214 shares during the period. 58.60% of the stock is currently owned by institutional investors.

KORU Medical Systems Price Performance

Shares of NASDAQ KRMD opened at $5.45 on Friday. The company has a fifty day moving average price of $5.72 and a 200 day moving average price of $4.56. KORU Medical Systems, Inc. has a 1-year low of $1.86 and a 1-year high of $6.61. The firm has a market cap of $252.44 million, a PE ratio of -68.13 and a beta of 0.51. The company has a current ratio of 2.48, a quick ratio of 1.92 and a debt-to-equity ratio of 0.01.

Analysts Set New Price Targets

A number of analysts have recently issued reports on KRMD shares. Weiss Ratings reissued a “sell (d-)” rating on shares of KORU Medical Systems in a research report on Thursday, January 22nd. Wall Street Zen upgraded KORU Medical Systems from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 12th. Craig Hallum reaffirmed a “buy” rating and issued a $7.00 price target on shares of KORU Medical Systems in a report on Tuesday, January 13th. Lake Street Capital raised their price target on shares of KORU Medical Systems from $6.00 to $8.00 and gave the stock a “buy” rating in a research note on Monday, December 22nd. Finally, Canaccord Genuity Group increased their target price on shares of KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, KORU Medical Systems currently has a consensus rating of “Moderate Buy” and a consensus target price of $6.13.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.